Skip to content

Rocuronium Effective Dose for Laparoscopic Cholecystectomy

Rocuronium ED50 for Excellent Laparoscopic Conditions for Cholecistectomy: Dose-finding Adaptative Clinical Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03043157
Enrollment
30
Registered
2017-02-03
Start date
2017-02-15
Completion date
2017-03-02
Last updated
2017-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Relaxation

Brief summary

This is an adaptative study where each participant's rocuronium dose will depend on the previous patient's response, being higher if it was not enough and lower if it was more than enough.

Detailed description

Rocuronium is one of the most used neuromuscular blockers to help intubation and to relax abdominal wall for laparoscopic surgery. Rocuronium intubation dose can be enough for intubation but not last enough for excellent laparoscopic conditions. There is little variation in time from anesthesia induction to the end of the laparoscopy for cholecystectomy and avoiding excess rocuronium dose can help providing excellent conditions and fast track extubation. Dixon's up-and-down method will guide this dose-finding study for the ED50.

Interventions

DRUGrocuronium

intravenous rocuronium infusion

Sponsors

Brasilia University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

Participant receives hypnotic (propofol) before we use the drug

Intervention model description

Dose-finding using Dixon's up-and-down adaptative clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* general anesthesia

Exclusion criteria

* deny participation

Design outcomes

Primary

MeasureTime frameDescription
Excellent laparoscopic conditions30 minutesSubjective laparoscopic conditions for surgery, assessed by the main surgeon, as excellent or not

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026